Close

Recipharm winner of TRACKTS Award 2017

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.
- Advertisement -

Recipharm is proud to announce that our programme designed to implement our standard solution for serialisation across our manufacturing facilities, has been recognised as an example of best practice at the TRACKTS Awards 2017.

The programme won the PHARMA 4.0 Tracksters award for the best execution of a track and trace system at the ceremony on September 28, following an evaluation process which assessed the project’s methodology, use of technology and innovation.

In 2016, we committed to invest 40 million euros into our serialisation programme and to lead the market in terms of our readiness for the European Falsified Medicines Directive (FMD).

The award recognised the implementation programme at Recipharm’s facility in Lisbon, which is now equipped to provide serialisation and aggregation capabilities to customers and is already supplying products to China, South Korea and Saudi Arabia.

Recipharm’s programme is intends to ensure a cohesive and consistent approach to serialisation implementation across all our manufacturing sites and is used to identify, purchase, install and qualify systems in line with customer requirements.

For more information about Recipharm’s serialisation capabilities visit https://www.recipharm.com/additional-services/serialisation

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.

EMA Initiates Data Sharing Pilot for New Approach Methodologies

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »